Aclarion partners with PRIA Healthcare for Nociscan reimbursement strategy Jun 9, 2026 07:01AM
Aclarion rejects Echo Lake Capital's $4 per share acquisition offer Jun 8, 2026 07:05AM
Aclarion partners with Institute of Neuro Innovation for Nociscan expansion Jun 3, 2026 06:00AM
Aclarion adds Beverly Hills spine practice to CLARITY trial May 7, 2026 06:01AM
Aclarion signs second commercial deal with Weill Cornell Medicine May 5, 2026 06:01AM


Apr 30, 2026 06:01AM Aclarion reports 196% growth in scan volumes for Q1
Apr 28, 2026 06:00AM Aclarion names Daniel Keefe commercial director for western US
Apr 8, 2026 08:02AM Aclarion partners with Weill Cornell Medicine for spine pain study
Mar 19, 2026 09:26AM Aclarion adopts one-year stockholder rights plan
Feb 5, 2026 06:00AM Aclarion says cash runway extends into 2028, ends equity facilities
Feb 3, 2026 06:01AM Aclarion partners with Source Healthcare to expand Nociscan in Los Angeles
Jan 13, 2026 06:01AM Aclarion raises $10.4 million, extends cash runway into 2028
Jan 8, 2026 07:00AM Aclarion reports 114% quarterly growth in scan volumes, raises $22M
Jan 6, 2026 06:00AM Aclarion enrolls first patients at Northwestern, Scripps sites for CLARITY trial
Dec 4, 2025 08:02AM Aclarion publishes Nociscan article in spine surgery journal
Dec 2, 2025 08:01AM Aclarion names Jason Brosniak commercial director for eastern U.S.
Nov 5, 2025 06:00AM Aclarion hires Dan Isherwood as UK commercial director
Oct 14, 2025 06:11AM Aclarion reports 89% surge in scan volumes, advances trial
Oct 13, 2025 06:01AM Aclarion presents MR spectroscopy pain biomarker tech at London conference
Oct 9, 2025 06:00AM Aclarion to Present at the LD Micro Main Event XIX
Aug 5, 2025 06:01AM Aclarion reports 132% growth in Nociscan scan volume
Jul 7, 2025 04:02PM Aclarion (ACON) postpones annual shareholder meeting to July 21
Mar 31, 2025 07:03AM Aclarion (ACON) Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives
Mar 26, 2025 07:01AM Aclarion (ACON) Announces 1:27 Reverse Share Split
Mar 6, 2025 09:35AM Aclarion (ACON) Announces Expansion Plans with RadNet Affiliates in NY and NJ
Mar 3, 2025 07:08AM Aclarion (ACON) Announces First Commercial Agreement with Scripps Health
Feb 11, 2025 07:58AM Aclarion (ACON) Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy Data Processing
Nov 14, 2024 05:00PM Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Sep 27, 2024 06:57AM Aclarion's (ACON) Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Sep 12, 2024 06:57AM Aclarion (ACON) Provides Corporate Update on Nociscan AI Technology Milestones